CS logo
small CS logo
NeuroStudies

Decatur, Georgia, United States
Research institute in Decatur, Georgia
755 Commerce Dr Suite 200, Decatur, GA 30030

About NeuroStudies


"NeuroStudies is an experienced, clinical research group dedicated to the development of safe and effective treatments to help prevent memory loss and dementia for patients around the world. With secure, modern facilities and a committed staff, we not only remain on the forefront of medical and technology advancements, but also provide our patients and study participants with the best clinical trial experience possible. Our team works around-the-clock to help ensure patients are receiving the highest standard of care, and are well-informed, comfortable and safe."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Pfizer
3
TauRx Therapeutics Ltd
2
Alector Inc.
1
Alzheon Inc.
1
Cognito Therapeutics, Inc.
1
Neuraly, Inc.
1
NeuroDerm Ltd.
1
Novartis Pharmaceuticals
1
Zhejiang Hisun Pharmaceutical Co. Ltd.
1
Total Rows: 9

Clinical Trials at NeuroStudies


During the past decade, NeuroStudies conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11000011111122110022110000111100Started TrialsCompleted Trails201520162017201820192020202120220123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients
2008-06-01
2013-08-01
Terminated
901
Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients
2008-01-01
2012-11-01
Terminated
1,100
Study Evaluating The Long-Term Safety And Efficacy Of Subcutaneous Bapineuzumab
2009-06-01
2012-09-01
Terminated
62
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
2012-10-01
2016-05-01
Completed
800
Open-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
2014-08-01
2017-05-01
Terminated
913
A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease
2015-11-30
2020-04-30
Terminated
480
Efficacy and Safety of AD-35 in Treatment of Subjects With Mild to Moderate Alzheimer's Disease
2018-10-04
2020-12-31
Unknown status
55
Efficacy, Safety and Tolerability Study of ND0612 vs. Oral IR-LD/CD in Subjects With PD Experiencing Motor Fluctuations
2019-08-27
2023-10-30
Active, not recruiting
381

Rows per page:

1–12 of 12

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "NeuroStudies" #1 sponsor was "Pfizer" with 3 trials, followed by "TauRx Therapeutics Ltd" with 2 trials sponsored, "Alector Inc." with 1 trials sponsored, "Alzheon Inc." with 1 trials sponsored and "Cognito Therapeutics, Inc." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "NeuroStudies" #1 collaborator was "National Institute on Aging (NIA)" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Banner Alzheimer's Institute" with 1 trials as a collaborator and "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at NeuroStudies


According to Clinical.Site data, the most researched conditions in "NeuroStudies" are "Alzheimer Disease" (5 trials), "Alzheimer Disease, Early Onset" (2 trials), "Alzheimer's Disease" (2 trials), "Alzheimer Disease 1" (1 trials) and "Alzheimer Disease 10" (1 trials). Many other conditions were trialed in "NeuroStudies" in a lesser frequency.

Clinical Trials Intervention Types at NeuroStudies


Most popular intervention types in "NeuroStudies" are "Drug" (11 trials), "Biological" (1 trials), "Combination Product" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "bapineuzumab" (3 trials), "Placebo" (2 trials), "placebo" (2 trials), "AD-35 60mg group" (1 trials) and "AL002" (1 trials). Other intervention names were less common.

Clinical Trials Genders at NeuroStudies


The vast majority of trials in "NeuroStudies" are 12 trials for "All" genders.

Clinical Trials Status at NeuroStudies


Currently, there are NaN active trials in "NeuroStudies". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in NeuroStudies, undefined suspended trials, and 5 terminated clinical trials to date.
Out of the total trials that were conducted in NeuroStudies, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status

Departments of NeuroStudies


NeuroStudies has several departments that took part in Clinical trials: "NeuroStudies.net, LLC" - 23 trials
Departments List
Name
City
Trials